SGLT2 inhibitor - Globe Thesis

Keyword [SGLT2 inhibitor] Result: 1 - 20 \| Page: 1 of 2
1.	Design, Synthesis And Antidiabetic Activities Of Novel Sodium-glucose Co-transporter 2(SGLT2) Inhibitors
2.	The Efficacy And Safety Of Sodium Glucose CO-Transport2(SGLT2) Inhibitor For Type2Diabetes:Systematic Review
3.	Efficacy Of Sodium-glucose Cotransporter2(SGLT2) Inhibitor Treatment For Diabetic Patients Achieving HbA1c <7.0%: Systematic Review And Meta-analysis
4.	Effect Of SGLT2 Inhibitor On Insulin Sensitivity And β Cell Function And Protection Of Diabetic Nephropathy
5.	Effects Of Sodium Glucose Cotransporter-2 Inhibitors On The Risk Of Bone Fracture In Patients With Type 2 Diabetes: A Systematic Review
6.	Design,Synthesis And Biological Evaluation Of Novel Sodium Glucose Co-transporter 2(SGLT2)Inhibitors
7.	The Role And Mechanism Of SGLT2 Inhibitors In The Prevention And Treatment Of Non-alcoholic Fatty Liver Disease
8.	Meta Analysis Of The Effect Of SGLT2 Inhibitor On Oxidative Stress In Overweight Or Obese Type 2 Diabetic Patients
9.	The Renal Protective Effect And Safety Of SGLT2 Inhibitors On Diabetic Nephropathy: A Systematic Review And Meta-analysis
10.	Effects Of SGLT2 Inhibitors On The Prognosis And Prevention In Patient With Chronic Heart Failure
11.	The Study About Effect And Mechanism Of Liraglutide And Dapagliflozin On Cardiac Function In Type 2 Diabetic Patients
12.	Meta-analysis Of Efficacy And Safety Of SGLT2 Inhibitors In The Treatment Of Type 2 Diabetes Mellitus With Cardiovascular Disease
13.	The Effects Of SGLT2 Inhibitor On Stroke And Adverse Events In Patients With Type 2 Diabetes Mellitus:Systematic Review And Meta-analysis
14.	The Effect Of SGLT2 Inhibitor On Blood Lipid Profile In Adult Patients With Type 2 Diabetes Mellitus: A Meta-analysis
15.	GC/MS-based Metabonomic Analysis Explores Mechanism Of SGLT2i In Protecting Renal Tubules In Diabetic Kidney Disease
16.	Effects Of Empagliflozin On Carotid Intima-media Thickness And Serum High-sensitivity C-reactive Protein In Patients With Type 2 Diabetes Mellitus
17.	Effect Of Empagliflozin On Urine Albumin-to-creatinine Ratio And Cystatin C In Patients With Type 2 Diabetes
18.	Clinical Study Of SGLT2 Inhibitor Combined With RAAS Blocker In Early Diabetic Nephropathy
19.	Effects Of SGLT2 Inhibitors On Hospitalization For Heart Failure In Type 2 Diabetes:a Meta-analysis Of Randomized Controlled And Observational Studies
20.	Research On SGLT2 Inhibitor Alleviating Doxorubicin Induced Cardiotoxicity
<<First <Prev Next> Last>> Jump to